Therapeutic potential of targeting glutamate receptors in Parkinson's disease.
about
Pharmacological Treatments Inhibiting Levodopa-Induced Dyskinesias in MPTP-Lesioned Monkeys: Brain Glutamate Biochemical CorrelatesPharmacological stimulation of metabotropic glutamate receptor type 4 in a rat model of Parkinson's disease and L-DOPA-induced dyskinesia: Comparison between a positive allosteric modulator and an orthosteric agonist.Molecular imaging of levodopa-induced dyskinesias.New and emerging medical therapies in Parkinson's disease.IDH1 Associated with Neuronal Apoptosis in Adult Rats Brain Following Intracerebral Hemorrhage.Amantadine extended-release capsules for levodopa-induced dyskinesia in patients with Parkinson's disease.
P2860
Therapeutic potential of targeting glutamate receptors in Parkinson's disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Therapeutic potential of targeting glutamate receptors in Parkinson's disease.
@en
type
label
Therapeutic potential of targeting glutamate receptors in Parkinson's disease.
@en
prefLabel
Therapeutic potential of targeting glutamate receptors in Parkinson's disease.
@en
P2860
P1476
Therapeutic potential of targeting glutamate receptors in Parkinson's disease
@en
P2093
Clare Finlay
P2860
P2888
P304
P356
10.1007/S00702-014-1176-4
P50
P577
2014-02-21T00:00:00Z